Direct Vascular Effects of HMG-CoA Reductase Inhibitors

By Laufs U.   Liao J.K.  

Trends in Cardiovascular Medicine, Vol. 10, Iss. 4, 2000-05 ,pp. : 143-148

Elsevier

Access to resources Recommend Favorite

Coronary artery bypass grafting within the first year after treatment of large acute myocardial infarctions with angioplasty or fibrinolysis

By Kjaergard Henrik   Nielsen Per Hostrup   Andreasen Jan Jesper   Steinbrüchel Daniel   Andersen Lars Ib   Rasmussen Klaus   Andersen Henning Rud   Nielsen Torsten Toftegaard   Mortensen Leif Spange  

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 1, 2006-02 ,pp. : 25-28

Informa Healthcare

Access to resources Recommend Favorite

HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

By Kunieda Y.   Nakagawa K.   Nishimura H.   Kato H.   Ukimura N.   Yano S.   Kawano H.   Kimura S.   Nakagawa M.   Tsuji H.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study

By Takagi Atsushi   Tsurumi Yukio   Ishizuka Naoko   Omori Hisako   Arai Kotaro   Hagiwara Nobuhisa   Kasanuki Hiroshi  

Heart and Vessels, Vol. 21, Iss. 5, 2006-09 ,pp. : 298-301

Springer Publishing Company

Access to resources Recommend Favorite

Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease

By Filipovic M.   Jeger R.   Probst C.   Girard T.   Pfisterer M.   Gurke L.   Skarvan K.   Seeberger M.D.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1767-1776

Elsevier

Access to resources Recommend Favorite